On the definition of dermatological disease. Part 1: conceptual frameworks.
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
accepted:
25
05
2022
pubmed:
29
5
2022
medline:
29
5
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Little attention is paid to disease definition in dermatology and how such definitions come about, yet defining a disease is a fundamental step upon which all subsequent clinical management and prognostic judgements depend. Developing diagnostic criteria is also a critically important step for research purposes so that studies referring to groups of people can be compared in a meaningful way. This short review introduces the concepts of regressive and progressive nosology, and how definitions of a dermatological disease can evolve in a useful way as knowledge about that disease increases. It also highlights the dangers of panchrestons - names that try to explain all yet end up explaining very little. It also considers approaches to disease definition, such as whether a binary yes/no or continuous approach is more appropriate. Conceptual frameworks including essentialistic vs. nominalistic approaches using the biomedical or biopsychosocial perspectives are articulated. The review then illustrates hazards of underdiagnosis and overdiagnosis, and introduces the notion of 'disease mongering' - the selling of disease in order to promote the use of medicines. The review concludes with a reaffirmation of the importance of defining dermatological disease, and why any new diagnostic criteria must be shown to increase predictive ability before they are assimilated into clinical practice and research.
Identifiants
pubmed: 35633083
doi: 10.1111/ced.15279
pmc: PMC9795908
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1805-1811Informations de copyright
© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Références
Ann Allergy Asthma Immunol. 2020 Jan;124(1):36-43
pubmed: 31622670
Aust N Z J Psychiatry. 2019 Sep;53(9):866-877
pubmed: 30895799
J Allergy Clin Immunol. 2006 Jul;118(1):209-13
pubmed: 16815157
Arch Dermatol. 1999 May;135(5):583-6
pubmed: 10328200
Ann Intern Med. 2021 Feb;174(2):286-287
pubmed: 33587872
J Int Med Res. 1976;4(4):228-31
pubmed: 1026547
Br J Dermatol. 1994 Sep;131(3):383-96
pubmed: 7918015
BMJ. 1994 Apr 9;308(6934):929-30
pubmed: 8173393
Br J Dermatol. 2021 Dec;185(6):1240-1241
pubmed: 34319584
Lancet. 1960 May 21;1(7134):1085-93
pubmed: 14428616
PLoS Med. 2008 May 27;5(5):e106
pubmed: 18507498
Dermatol Clin. 2019 Jan;37(1):65-71
pubmed: 30466689
Lancet. 1996 Aug 31;348(9027):594-6
pubmed: 8774576
J Allergy Clin Immunol. 2004 May;113(5):832-6
pubmed: 15131563
N Engl J Med. 2005 Jun 2;352(22):2314-24
pubmed: 15930422
Br J Dermatol. 2006 Jul;155(1):23-6
pubmed: 16792747
Br J Dermatol. 2003 Jun;148(6):1278-9; author reply 1279
pubmed: 12828770
Science. 1977 Apr 8;196(4286):129-36
pubmed: 847460
Clin Exp Dermatol. 1981 Jan;6(1):1-21
pubmed: 7273472
Lancet Respir Med. 2017 Mar;5(3):177-178
pubmed: 28266327
J Allergy Clin Immunol. 2004 Jul;114(1):150-8
pubmed: 15241359
PLoS Med. 2006 Apr;3(4):e191
pubmed: 16597180